Article

Chondrolysis of the tibial plateau caused by articular aspergillosis after ACL autograft reconstruction: management with a fresh osteochondral allograft: a case report.

Department of Orthopaedic Surgery, UC Davis Medical Center, Sacramento, CA 95817, USA.
The Journal of Bone and Joint Surgery (Impact Factor: 4.31). 11/2011; 93(21):e1241-6. DOI: 10.2106/JBJS.J.00782
Source: PubMed
1 Bookmark
 · 
62 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aspergillus can cause invasive disease of various organs especially in patients with weakened immune systems. Aspergillus synovitis and arthritis are uncommon types of involvement due to this infection. Approaches to fungal osteoarticular infections are based on only case reports. This paper presents a rare case of chronic granulomatous Aspergillus synovitis in an immunocompromised 5-year old girl who was treated for acute lymphoblastic leukemia.
    Mediterranean Journal of Hematology and Infectious Diseases 01/2013; 5(1):e2013043. DOI:10.4084/mjhid.2013.043
  • [Show abstract] [Hide abstract]
    ABSTRACT: Management of fungal osteomyelitis and fungal septic arthritis is challenging, especially in the setting of immunodeficiency and conditions that require immunosuppression. Because fungal osteomyelitis and fungal septic arthritis are rare conditions, study of their pathophysiology and treatment has been limited. In the literature, evidence-based treatment is lacking and, historically, outcomes have been poor. The most common offending organisms are Candida and Aspergillus, which are widely distributed in humans and soil. However, some fungal pathogens, such as Histoplasma, Blastomyces, Coccidioides, Cryptococcus, and Sporothrix, have more focal areas of endemicity. Fungal bone and joint infections result from direct inoculation, contiguous infection spread, or hematogenous seeding of organisms. These infections may be difficult to diagnose and eradicate, especially in the setting of total joint arthroplasty. Although there is no clear consensus on treatment, guidelines are available for management of many of these pathogens.
    The Journal of the American Academy of Orthopaedic Surgeons 06/2014; 22(6):390-401. DOI:10.5435/JAAOS-22-06-390 · 2.40 Impact Factor